Fluorofenidone Affects Hepatic Stellate Cell Activation in Hepatic Fibrosis by Targeting the TGF‑β1/Smad and MAPK Signaling Pathways
Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2019.7548
Full Text
Open PDFAbstract
Available in full text
Date
May 6, 2019
Authors
Publisher
Spandidos Publications